Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial flagellin is the principal protein subunit of the filament portion of the bacterial flagellum, which is the organelle responsible for motility in flagellated bacteria[1][2]. Flagellin monomers (~40 kDa) assemble into a helical, hollow filament structure, forming the propeller-like apparatus that drives bacterial movement[1][2][3]. The flagellin protein is highly conserved at the N- and C-terminal regions, responsible for polymerization and core structure, but displays significant variability in its central region[1]. Flagellin is a potent immunostimulatory molecule, recognized by the host’s immune system (notably Toll-like receptor 5, TLR5), leading to rapid activation of inflammatory pathways[1]. As such, flagellin is a key virulence factor in many pathogenic bacteria, playing roles in both infection (by facilitating bacterial motility and colonization) and immune evasion (due to its antigenic variability)[3]. It is also being investigated as a vaccine adjuvant and as a model for understanding host-pathogen interactions. Caveats/Notes: - Bacterial flagellin is a structural protein and not a receptor, enzyme, or transporter, but is a validated immune target and therapeutic research focus[1][3]. - No approved drugs currently target flagellin therapeutically, but its immune-stimulating properties are under investigation for vaccine adjuvants and anti-infective strategies[1][3]. - Some confusion may arise because “flagellin” refers to a family of proteins across bacterial species, but it is well defined as the primary component of the bacterial flagellar filament[1].
For adjuvant or vaccine strategies: Activates innate immunity via Toll-like receptor 5 (TLR5) - For targeting bacteria: Antibodies or immune responses can neutralize bacterial motility or flagellin-mediated signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial flagellin.